These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17372586)

  • 21. Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab.
    Darnige L; Peffault de Latour R; Zemori L; Socié G; Fischer AM; Helley D;
    Br J Haematol; 2011 Jun; 153(6):789-91. PubMed ID: 21457219
    [No Abstract]   [Full Text] [Related]  

  • 22. Which patients with paroxysmal nocturnal hemoglobinuria (PNH) should be treated with eculizumab? ASH evidence-based review 2008.
    Haspel RL; Hillmen P
    Hematology Am Soc Hematol Educ Program; 2008; ():35. PubMed ID: 19074053
    [No Abstract]   [Full Text] [Related]  

  • 23. Paroxysmal nocturnal hemoglobinuria--hemolysis before and after eculizumab.
    Risitano AM; Notaro R; Luzzatto L; Hill A; Kelly R; Hillmen P
    N Engl J Med; 2010 Dec; 363(23):2270-2. PubMed ID: 21121856
    [No Abstract]   [Full Text] [Related]  

  • 24. Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria.
    Schrezenmeier H; Höchsmann B
    Expert Rev Hematol; 2009 Feb; 2(1):7-16. PubMed ID: 21082989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of eculizumab to correct paroxysmal cold hemoglobinuria.
    Gregory GP; Opat S; Quach H; Shortt J; Tran H
    Ann Hematol; 2011 Aug; 90(8):989-90. PubMed ID: 21110191
    [No Abstract]   [Full Text] [Related]  

  • 26. Durable resolution of recurrent microvascular small bowel ischaemia and severe abdominal pain by eculizumab in paroxysmal nocturnal haemoglobinuria.
    Grigg A; Brown M; Szer J
    Intern Med J; 2010 Nov; 40(11):794-5. PubMed ID: 21108715
    [No Abstract]   [Full Text] [Related]  

  • 27. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Kathula SK
    N Engl J Med; 2006 Dec; 355(26):2786; author reply 2787-8. PubMed ID: 17192547
    [No Abstract]   [Full Text] [Related]  

  • 28. [Paroxysmal nocturnal hemoglobinuria].
    Geffray L
    Rev Med Interne; 2008 Nov; 29(11):957-61. PubMed ID: 18801601
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Hall C; Marsh JC; Elebute M; Bombara MP; Petro BE; Cullen MJ; Richards SJ; Rollins SA; Mojcik CF; Rother RP
    N Engl J Med; 2004 Feb; 350(6):552-9. PubMed ID: 14762182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eculizumab.
    Parker CJ; Kar S; Kirkpatrick P
    Nat Rev Drug Discov; 2007 Jul; 6(7):515-6. PubMed ID: 17715500
    [No Abstract]   [Full Text] [Related]  

  • 31. [Paroxysmal nocturnal hemoglobinuria: challenging diagnosis in internal medicine].
    Morneau C
    Rev Med Interne; 2009 Oct; 30(10):931-4. PubMed ID: 19683844
    [No Abstract]   [Full Text] [Related]  

  • 32. Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria.
    Hill A; Rother RP; Hillmen P
    Haematologica; 2005 Dec; 90(12 Suppl):ECR40. PubMed ID: 16464755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):333-46. PubMed ID: 19327587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria.
    Emadi A; Brodsky RA
    Am J Hematol; 2009 Oct; 84(10):699-701. PubMed ID: 19705437
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
    Dmytrijuk A; Robie-Suh K; Cohen MH; Rieves D; Weiss K; Pazdur R
    Oncologist; 2008 Sep; 13(9):993-1000. PubMed ID: 18784156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Young NS; Schubert J; Brodsky RA; Socié G; Muus P; Röth A; Szer J; Elebute MO; Nakamura R; Browne P; Risitano AM; Hill A; Schrezenmeier H; Fu CL; Maciejewski J; Rollins SA; Mojcik CF; Rother RP; Luzzatto L
    N Engl J Med; 2006 Sep; 355(12):1233-43. PubMed ID: 16990386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab.
    Kelly R; Arnold L; Richards S; Hill A; Bomken C; Hanley J; Loughney A; Beauchamp J; Khursigara G; Rother RP; Chalmers E; Fyfe A; Fitzsimons E; Nakamura R; Gaya A; Risitano AM; Schubert J; Norfolk D; Simpson N; Hillmen P
    Br J Haematol; 2010 May; 149(3):446-50. PubMed ID: 20151973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy in PNH: another eculizumab baby.
    Marasca R; Coluccio V; Santachiara R; Leonardi G; Torelli G; Notaro R; Luzzatto L
    Br J Haematol; 2010 Sep; 150(6):707-8. PubMed ID: 20553271
    [No Abstract]   [Full Text] [Related]  

  • 39. Eculizumab: new drug. Nocturnal paroxystic haemoglobinuria: fewer transfusions.
    Prescrire Int; 2009 Feb; 18(99):13. PubMed ID: 19388209
    [No Abstract]   [Full Text] [Related]  

  • 40. From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging.
    Risitano AM; Imbriaco M; Marando L; Seneca E; Soscia E; Malcovati L; Iori AP; Pane F; Notaro R; Matarazzo M
    Br J Haematol; 2012 Aug; 158(3):415-8. PubMed ID: 22571809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.